Multimodality Imaging in the Evaluation of Cardiovascular Manifestations of Malignancy

Table 2

Chemotherapeutic agents associated with left ventricular dysfunction.

---

Chemotherapy agents

---

Anthracyclines

  Doxorubicin

 Epirubicin

 Idarubicin

Alkylating agents

 Cyclophosphamide

  Ifosfamide

Antimetabolites

 Docetaxel

Monoclonal antibody-based tyrosine kinase inhibitors

 Bevacizumab

 Trastuzumab

Proteasome inhibitor

 Bortezomib

Small molecule tyrosine kinase inhibitors

 Dasatinib

  Imatinib mesylate

  Lapatinib

  Sunitinib

---